Ligand Pharmaceuticals stockLGND
Ligand Pharmaceuticals trades at $299.00, 8.5% below its 52-week high (Jul 8, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +58.1% year to date, +57.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 4, 2027.
Ratings, candles, signals and the screener for LGND — after you log in
Open the terminalFrequently asked questions about Ligand Pharmaceuticals
What is the Ligand Pharmaceuticals stock price?
At the close on Nov 5, 2026: $299.00 (−5.42% on the day). 52-week high: $326.63 on Jul 8, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ligand Pharmaceuticals report earnings?
The next quarterly report is on Mar 4, 2027. Last quarter, earnings per share changed −14% year over year, revenue −32%.
Does Ligand Pharmaceuticals pay dividends?
No, Ligand Pharmaceuticals does not pay dividends.
Where does Ligand Pharmaceuticals trade and how to buy it?
Ticker LGND, exchange Nasdaq, listed since 1992. You can buy it through a broker with access to US exchanges.
Should I buy Ligand Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for LGND are in the terminal after you log in.